EXELTIS RETHINKING HEALTHCARE
LIVE

Serial Number

79142730

Owner

CHEMO IBERICA, S.A.

Attorney

Arturo Perez-Guerrero

Filing Date

Sep 11, 2013

Add to watchlist:

No watchlists yet
View on USPTO

EXELTIS RETHINKING HEALTHCARE Trademark

Serial Number: 79142730 • Registration: 4792387

EXELTIS RETHINKING HEALTHCARE is a trademark filed by CHEMO IBERICA, S.A. on September 11, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CHEMO IBERICA, S.A. (5 trademarks)

Gran Vía Carlos III, 98, 7°
Barcelona E-08028 , ES

Entity Type: 99

Trademark Details

Filing Date

September 11, 2013

Registration Date

August 18, 2015

Published for Opposition

June 2, 2015

Goods & Services

[ Chemical, biological and pharmaceutical research services * ; [ all ] * none of * the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]

[ Surgical apparatus and instruments, medical instruments for treating gynecological disorders, [ ophthalmological ] * ophthalmic * disorders, dermatological disorders, and respiratory and metabolic disorders; Medical test kits for diabetes monitoring for home use; orthopedic devices for diagnostic and therapeutic [ use ] * purposes * ; suture materials ]

Pharmaceutical preparations for [ use in ] the treatment of [ ophthalmic diseases and disorders, dermatological diseases and disorders, digestive diseases and disorders, ] gynecological diseases and disorders; [ reagents for use in pregnancy tests; ] medical diagnostic reagents for use in ovulation tests; [ medical diagnostic reagents for use in testing for diabetes; ] contraceptives; pharmaceutical preparations for use in the treatment of hormonal diseases and disorders [ , blood disorders, cancer, cardiovascular diseases, vascular diseases, gastro-intestinal diseases, genitourinary diseases, * gastrointestinal disease, genitourinary disorders, * immunological diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of neurological diseases and disorders, psychiatric diseases, diseases of the central nervous system, diseases of the musculoskeletal system, diseases of the respiratory system, diseases of the circulatory system, * circulatory diseases, * viral diseases, glaucoma, dental and mouth diseases, headaches, migraines, obesity, cholesterol, in liver treatment * treatment of the liver * ] ; nutraceutical preparations for use as a dietary supplement; pharmaceutical [ preparations ] * products * for treating [ blood pressure and rheumatism; veterinary preparations for the treatment of digestive diseases and disorders, ] gynecological diseases and disorders [ , blood disorders, cancer, the treatment of cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunological diseases, * disorders, * infectious diseases, inflammatory diseases, metabolic diseases and disorders, the treatment of neurological diseases, the treatment of viral diseases, glaucoma, dental and oral diseases, headaches, migraines, obesity, liver treatment * treatment of the *, cholesterol; nutraceutical veterinary preparations for use as a dietary supplement; veterinary preparations for the treatment of blood pressure and for rheumatism; and dietetic foods, namely, crackers adapted for medical use * ; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]

[ Sales promotion for third parties, business management assistance; [ consulting ] * consultancy * on business management and marketing studies; ] presentation of goods on [ any kind of ] * all * communication media for retail sale [ ; commercial administration of licenses for the goods and services of others; organization of exhibitions, [ trade fairs or congresses for business ] * trade fairs and conventions for commercial * or advertising purposes, all relating to pharmaceutical, veterinary and biotechnological companies and for pharmaceutical, veterinary and biotechnological products * ; but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jan 21, 2026 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jan 21, 2026 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 30, 2025 APRE
TEAS SECTION 71 & 15 RECEIVED
Aug 18, 2025 ES75
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 23, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 23, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 23, 2025 REAP
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Aug 18, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
Jul 14, 2023 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
May 16, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 4, 2023 INPS
INVALIDATION PROCESSED
Apr 4, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 12, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 12, 2022 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Jun 12, 2022 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 6, 2022 APRE
TEAS SECTION 71 RECEIVED
Aug 16, 2021 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 18, 2020 REM3
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Nov 29, 2018 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 12, 2018 INPR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Mar 13, 2018 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Mar 12, 2018 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 12, 2018 APRE
LIMITATION FROM THE IB EXAMINED AND ENTERED
Nov 28, 2017 LIME
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Oct 16, 2017 CORR
CORRECTION UNDER SECTION 7 - PROCESSED
Oct 14, 2017 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 14, 2017 APRE
LIMITATION OF GOODS RECEIVED FROM IB
Oct 6, 2017 LIMG
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 22, 2017 CRCV
LIMITATION OF GOODS RECEIVED FROM IB
Sep 21, 2017 LIMG
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
May 2, 2017 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 1, 2017 INPR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Jul 6, 2016 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Jul 1, 2016 COC.
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 20, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 2, 2016 FICS
FINAL DISPOSITION PROCESSED
Feb 2, 2016 FIMP
LIMITATION OF GOODS RECEIVED FROM IB
Dec 18, 2015 LIMG
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 18, 2015 FICR
EXPARTE APPEAL TERMINATED
Aug 19, 2015 EXPT
REGISTERED-PRINCIPAL REGISTER
Aug 18, 2015 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 7, 2015 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 22, 2015 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 22, 2015 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jun 2, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Jun 1, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 13, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 13, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 27, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 27, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 27, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 27, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 27, 2015 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2015 CRFA
ASSIGNED TO LIE
Mar 9, 2015 ALIE
EX PARTE APPEAL-INSTITUTED
Mar 3, 2015 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Mar 3, 2015 JURT
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 2, 2015 ERFR
EXPARTE APPEAL RECEIVED AT TTAB
Mar 2, 2015 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 29, 2014 GNFN
FINAL REFUSAL E-MAILED
Aug 29, 2014 GNFR
FINAL REFUSAL WRITTEN
Aug 29, 2014 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2014 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 25, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 25, 2014 REAP
REFUSAL PROCESSED BY IB
Mar 14, 2014 RFNT
APPLICATION FILING RECEIPT MAILED
Feb 28, 2014 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 25, 2014 RFCS
REFUSAL PROCESSED BY MPU
Feb 25, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 25, 2014 RFCR
NON-FINAL ACTION WRITTEN
Feb 24, 2014 CNRT
ASSIGNED TO EXAMINER
Feb 24, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 21, 2014 REPR